Results 181 to 190 of about 1,724 (248)

Microenvironment‐Responsive Drug Delivery Systems for Ocular Surface Diseases: Mechanisms, Applications, and Translational Challenges

Small Science, Volume 6, Issue 8, August 2026.
Microenvironment‐responsive drug delivery systems overcome ocular physiological barriers by responding to temperature, pH, ions, reactive oxygen species, and enzymes. This review bridges material design, performance evaluation, and clinical translation, offering actionable insights for treating dry eye disease, infectious keratitis, and corneal ...
Jiamin Liu, Liangbo Chen, Yao Fu, Siyi Zhang   +3 more
wiley   +1 more source

Low-light driver drowsiness detection for real-time safety assistance using dual attention mechanisms in deep learning model. [PDF]

Sci Rep
Saxena S, Angel, Khurana M, Tiwari S, Shakya HK.   +4 more
europepmc   +1 more source

Biomarker‐Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease‐Modifying Treatments: A Consensus Statement by Belgian Experts

European Journal of Neurology, Volume 33, Issue 8, August 2026.
ABSTRACT Background The recent approval of disease‐modifying therapies (DMTs) for early Alzheimer's disease (AD) marks a major shift in clinical practice. Biomarker confirmation of amyloid pathology is now required alongside clinical assessment, and blood‐based tests are improving accessibility.
Tim Van Langenhove, Sara Van Mossevelde, Marijke Miatton, Jan De Lepeleire, Rose Bruffaerts, Jean Christophe Bier, Kurt Segers, Jurn Verschraegen, Mirko Petrovic, Manfredi Ventura, Haroun Jedidi, Ingo Beyer, Eric Mormont, Rik Vandenberghe, Aline Delva, Christian Gilles, Donatienne Van Weehaeghe, Gaëtane Picard, Peter De Deyn, Mélanie Strauss, Evert Thiery, Eric Salmon, Gert Cypers, Joris Vlaemynck, Katrin Gillis, Jan Versijpt, Maria Bjerke, Anne Sieben, Bernard Hanseeuw, Sebastiaan Engelborghs, Olivier Deryck, on behalf of the BeDeCo members   +31 more
wiley   +1 more source

Quantitative Analysis of Situation Awareness During Autonomous Vehicle Handover on the Da Vinci Research Kit. [PDF]

Sensors (Basel)
Levendovics T, Drexler DA, Ukhrenkov N, Takács Á, Haidegger T.   +4 more
europepmc   +1 more source

Opposing roles of DGAT‐mediated lipid droplet biogenesis in the regulation of ferroptosis sensitivity

The FEBS Journal, Volume 293, Issue 15, Page 4508-4532, August 2026.
Ferroptosis is driven by unrestricted peroxidation of polyunsaturated fatty acyl (PUFA) chains in membrane phospholipids. In triple‐negative breast cancer cells, lipid droplets (LDs) sequester dietary PUFAs, limiting their incorporation into membrane phospholipids, preventing mitochondrial damage, and reducing lipid peroxidation and ferroptosis.
Ana Kump, Leja Perne, Špela Koren, Eva Jarc Jovičić, Nastja Feguš, Carina Pinto Kozmus, Michele Wölk, Kristyna Brejchova, Maria Fedorova, Ondrej Kuda, Toni Petan   +10 more
wiley   +1 more source

VR Human-Centric Winter Lane Detection: Performance and Driving Experience Evaluation. [PDF]

Sensors (Basel)
Ortegon-Sarmiento T, Paderewski P, Kelouwani S, Gutierrez-Vela F, Uribe-Quevedo A.   +4 more
europepmc   +1 more source

Breastfeeding Intensity and Duration and Growth Trajectories in GDM Exposed Infants: The SWIFT Study

Pediatric Obesity, Volume 21, Issue 8, August 2026.
ABSTRACT Background Whether breastfeeding intensity, the relative amount of breastfeeding versus formula across the first year, relates to growth trajectories among infants exposed to gestational diabetes (GDM) in utero is unknown. Objective To identify growth trajectory patterns and associations with breastfeeding intensity among infants exposed to ...
Saralyn F. Foster, Elizabeth M. Widen, Joan C. Lo, Alexis King, Louise C. Greenspan, Baiyang Sun, Myles S. Faith, Marcela R. Abrego, Daniel Powers, Erica P. Gunderson   +9 more
wiley   +1 more source

Adaptive model predictive control for robust lateral motion tracking of semi-autonomous vehicles with dynamic parameter variation. [PDF]

Sci Rep
Yeneneh K, Yoseph B, Sufe G.
europepmc   +1 more source

GLP‐1 receptor agonists, metabolic syndrome, and Alzheimer's disease: Lessons and opportunities from the EVOKE trials

Journal of Neuroendocrinology, Volume 38, Issue 8, August 2026.
Abstract Metabolic syndrome and Alzheimer's disease (AD) are increasingly recognised as interconnected, sharing vascular, metabolic and inflammatory pathways that accelerate brain ageing and cognitive decline. This review critically examines the evidence that glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), initially developed for diabetes and ...
Pragati Gupta, Valeria Pozzilli, Anastasia De Giovanni, Elisabetta Sapio, Francesco Motolese, Fioravante Capone, Paolo Pozzilli   +6 more
wiley   +1 more source

Lane-change risk prediction model based on traffic context and driving styles. [PDF]

Sci Rep
Ren Y, Li F, Li Z.
europepmc   +1 more source